Histology
Non-Small Cell Carcinoma
CI-CAN-00001292Explore in graph →
1,752 active trials47 approved drugs589 evidence items
- NCIt
- C65151
Loading cancer entity…
Loading cancer entity…
Histology
CI-CAN-00001292Explore in graph →
Clinical trials
6,756 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,045)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00020709 | Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery | completed | Phase 3 | 840 | National Cancer Institute (NCI)NIH | 1 | Feb 27, 2013 | clinicaltrials |
| NCT00021060 | Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer | completed | Phase 2 / Phase 3 | 842 | National Cancer Institute (NCI)NIH | 1 |
| Feb 27, 2013 |
| clinicaltrials |
| NCT00622349 | Randomised Study Comparing Three Chemotherapy Regimens in Non-small Cell Lung Cancer | completed | Phase 3 | 707 | European Lung Cancer Working PartyOTHER | 4 | Jan 30, 2013 | clinicaltrials |
| NCT00090675 | Maintenance ZD1839 (IRESSA®) Following Completion of Front Line, Platinum-Based, Double Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer(IMAC/Herbst) | withdrawn | Phase 3 | 0 | AstraZenecaINDUSTRY | 0 | Jan 29, 2013 | clinicaltrials |
| NCT00931008 | Study to Evaluate SID 530 Compared to Taxotere | completed | Phase 3 | 42 | SK Chemicals Co., Ltd.INDUSTRY | 2 | Jan 24, 2013 | clinicaltrials |
| NCT00005838 | Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery | completed | Phase 3 | 756 | National Cancer Institute (NCI)NIH | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00136890 | PET Imaging in Potentially Surgically Resectable Non-small Cell Lung Cancers(ELPET) | completed | Phase 3 | 337 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Jan 15, 2013 | clinicaltrials |
| NCT00034879 | Iressa Expanded Access Program (EAP) | completed | Phase 3 | — | AstraZenecaINDUSTRY | 1 | Jan 4, 2013 | clinicaltrials |
| NCT00132665 | Trial to Evaluate Radiotherapy With or Without CBDCA in Elderly Patients With Non-Small Cell Lung Cancer (JCOG0301) | completed | Phase 3 | 200 | Japan Clinical Oncology GroupOTHER | 1 | Dec 7, 2012 | clinicaltrials |
| NCT01560195 | A Study of Pegylated rhG-CSF as Support to Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Receiving Chemotherapy | unknown | Phase 3 | 150 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Nov 6, 2012 | clinicaltrials |
| NCT00095199 | Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer | completed | Phase 3 | 939 | Eli Lilly and CompanyINDUSTRY | 2 | Oct 15, 2012 | clinicaltrials |
| NCT00707304 | Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer(FORTIS-M) | completed | Phase 3 | 742 | AgennixINDUSTRY | 23 | Aug 21, 2012 | clinicaltrials |
| NCT00050960 | Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer | completed | Phase 3 | 612 | Eisai Inc.INDUSTRY | 6 | Jul 13, 2012 | clinicaltrials |
| NCT01481259 | Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Nonsquamous Non-small Cell Lung Cancer | unknown | Phase 2 / Phase 3 | 120 | People's Hospital of Guangxi Zhuang Autonomous RegionOTHER | 1 | Jul 3, 2012 | clinicaltrials |
| NCT00442026 | Randomized Trial of Docetaxel and Gemcitabine Versus Gemcitabine in Elderly Patients With NSCLC | terminated | Phase 3 | 106 | Hellenic Oncology Research GroupOTHER | 1 | Jun 27, 2012 | clinicaltrials |
| NCT00478049 | Iressa as Second Line Therapy in Advanced NSCLC-Asia(ISTANA) | completed | Phase 3 | 163 | AstraZenecaINDUSTRY | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00042315 | A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Vinorelbine as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC) | terminated | Phase 3 | 490 | QLT Inc.INDUSTRY | 0 | May 23, 2012 | clinicaltrials |
| NCT01593293 | Pemetrexed With or Without Carboplatin for Elderly Non-squamous Non-small Cell Lung Cancer(ACE) | unknown | Phase 3 | 266 | Asan Medical CenterOTHER | 1 | May 8, 2012 | clinicaltrials |
| NCT00807066 | Randomized Gefitinib Trial(RANGE) | completed | Phase 3 | 1 | Fondazione Humanitas per la RicercaOTHER | 1 | Apr 23, 2012 | clinicaltrials |
| NCT00706862 | Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer(FORTIS-C) | unknown | Phase 3 | 1,100 | AgennixINDUSTRY | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00637910 | Tarceva Italian Lung Optimization tRial(TAILOR) | unknown | Phase 3 | 850 | Fatebenefratelli and Ophthalmic HospitalOTHER | 1 | Feb 24, 2012 | clinicaltrials |
| NCT01494558 | Study of Etoposide, Cisplatin, and Radiotherapy Versus Paclitaxel, Carboplatin and Radiotherapy to Treat Non-Small Cell Lung Cancer | completed | Phase 2 / Phase 3 | 200 | Chinese Academy of Medical SciencesOTHER | 0 | Dec 19, 2011 | clinicaltrials |
| NCT00136864 | Positron Emission Tomography (PET) Imaging in Stage III Non-small Cell Lung Cancer (PET START Trial) | completed | Phase 3 | 310 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Nov 18, 2011 | clinicaltrials |
| NCT00246727 | Effects of Selected Vegetable and Herb Mix (SV) on Advanced Non-small Cell Lung Cancer | unknown | Phase 3 | 300 | Sun Farm CorporationOTHER | 1 | Oct 31, 2011 | clinicaltrials |
| NCT00085826 | A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients | completed | Phase 3 | 600 | Astellas Pharma IncINDUSTRY | 1 | Oct 20, 2011 | clinicaltrials |
| NCT00437749 | A Study of CBT-1 and Paclitaxel With Carboplatin in Patients With Advanced Inoperable Non-small Cell Lung Cancer | terminated | Phase 3 | 214 | CBA ResearchINDUSTRY | 1 | Sep 9, 2011 | clinicaltrials |
| NCT00752115 | Combination Chemotherapy With Sildenafil Plus Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 2 / Phase 3 | 120 | Hamamatsu UniversityOTHER | 1 | Sep 7, 2011 | clinicaltrials |
| NCT00520676 | Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer | completed | Phase 3 | 260 | Eli Lilly and CompanyINDUSTRY | 6 | Aug 10, 2011 | clinicaltrials |
| NCT00234468 | Iressa vs Placebo as Maintenance Therapy in Locally Advanced NSCLC | terminated | Phase 3 | 490 | AstraZenecaINDUSTRY | 1 | May 20, 2011 | clinicaltrials |
| NCT00076388 | Iressa Versus Docetaxel (Taxotere) | completed | Phase 3 | 1,440 | AstraZenecaINDUSTRY | 25 | May 13, 2011 | clinicaltrials |
| NCT00391274 | Chemotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 211 | Eli Lilly and CompanyINDUSTRY | 1 | Apr 12, 2011 | clinicaltrials |
| NCT00737867 | Vinorelbine/Gemcitabine Versus Vinorelbine/Carboplatin in Advanced Non-small Cell Lung Cancer | completed | Phase 3 | 444 | The Norwegian Lung Cancer Study GroupNETWORK | 1 | Apr 4, 2011 | clinicaltrials |
| NCT00540280 | Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Clinical Early Stages of Non-small Cell Lung Cancer | suspended | Phase 3 | 10 | King Faisal Specialist Hospital & Research CenterOTHER | 0 | Mar 8, 2011 | clinicaltrials |
| NCT01301560 | Chemotherapy With or Without Radiosurgery for Asymptomatic Oligo Brain Metastasis | unknown | Phase 3 | 176 | Samsung Medical CenterOTHER | 1 | Feb 23, 2011 | clinicaltrials |
| NCT00312819 | Initial Assessment of the Effect of the Addition of Disulfiram (Antabuse) to Standard Chemotherapy in Lung Cancer | completed | Phase 2 / Phase 3 | 60 | Hadassah Medical OrganizationOTHER | 1 | Aug 31, 2010 | clinicaltrials |
| NCT00329472 | Efficacy Study of Induction Chemotherapy Before Surgery in Operable Non-small Cell Lung Cancer | withdrawn | Phase 3 | 0 | Samsung Medical CenterOTHER | 0 | Aug 27, 2010 | clinicaltrials |
| NCT00440414 | Trial of Pemetrexed Versus Erlotinib in Pretreated Patients With Non Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 320 | Hellenic Oncology Research GroupOTHER | 1 | Aug 19, 2010 | clinicaltrials |
| NCT01158170 | Prophylactic Cranial Irradiation in Erlotinib/Gefitinib-responders With Non-small Cell Lung Cancer (NSCLC) (RT1001) | unknown | Phase 3 | 200 | Zhejiang Cancer HospitalOTHER | 1 | Jul 8, 2010 | clinicaltrials |
| NCT01130766 | Asymptomatic Brain Metastasis in Non-small Cell Lung Cancer (NSCLC) | unknown | Phase 3 | 176 | Samsung Medical CenterOTHER | 1 | May 26, 2010 | clinicaltrials |
| NCT01124253 | Adjuvant Vinorelbine Plus Cisplatin(NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer(NSCLC)(Dengshan) | completed | Phase 3 | 250 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | May 17, 2010 | clinicaltrials |
| NCT00576914 | Adjuvant Vinorelbine Plus Cisplatin (NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer | unknown | Phase 3 | 1,108 | Chinese Academy of SciencesOTHER_GOV | 1 | Mar 9, 2010 | clinicaltrials |
| NCT01066195 | Pemetrexed (ALIMTA) and Gefitinib (IRESSA®) in Never-Smoker and Adenocarcinoma Patients With Non-Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy | unknown | Phase 3 | 129 | Samsung Medical CenterOTHER | 1 | Feb 10, 2010 | clinicaltrials |
| NCT01041833 | Effect of All-trans Retinoic Acid With Chemotherapy Based on Paclitaxel and Cisplatin As First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer and Expression of RAR-alfa and RAR-beta as Response Biomarker | unknown | Phase 3 | 230 | National Institute of CancerologíaOTHER_GOV | 1 | Jan 1, 2010 | clinicaltrials |
| NCT01003522 | Evaluation of Stents to Open Restricted Airways in Patients With Centrally Placed Non-small Cell Lung Cancer(RESTORE-AIR) | unknown | Phase 3 | 60 | Royal Marsden NHS Foundation TrustOTHER | 1 | Oct 28, 2009 | clinicaltrials |
| NCT00273507 | Neoadjuvant Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Stages IB, IIA, IIB, and IIIA/T3 | terminated | Phase 3 | 270 | Rigshospitalet, DenmarkOTHER | 1 | Sep 18, 2009 | clinicaltrials |
| NCT00300729 | Effect of Celecoxib on Survival in Patients With Advanced Non-Small Cell Lung Cancer Receiving Chemotherapy(CYCLUS) | unknown | Phase 3 | 319 | University Hospital, LinkoepingOTHER | 1 | Jun 30, 2009 | clinicaltrials |
| NCT00522639 | Predictive Value of FDG-PET-CT Scans for Patients With Lung Cancer Receiving Concurrent Chemo-Radiation(FDG-PET lung) | terminated | Phase 3 | 120 | Maastricht Radiation OncologyOTHER | 1 | Jun 30, 2009 | clinicaltrials |
| NCT00087802 | Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 383 | SanofiINDUSTRY | 1 | Apr 16, 2009 | clinicaltrials |
| NCT00430651 | Docetaxel and Carboplatin Versus Docetaxel as Second Line Treatment in Patients With Non-Small-Cell Lung Carcinoma (NSCLC) | completed | Phase 3 | 135 | Hellenic Oncology Research GroupOTHER | 1 | Jan 28, 2009 | clinicaltrials |
Data updated 23 days agoSource updated Feb 27, 2013source: clinicaltrials